Loading...
News2017-07-15T01:04:34-06:00

Categories

Archives

PRESS RELEASE: IVI Research Brief Discusses Limitations of ICER’s Analysis for JAK Inhibitors

As part of its Value Blueprints series, IVI’s latest research brief grapples with a question prompted by ICER’s recent assessment of RA therapies: Do conventional value assessments address the questions most relevant to real-world decisions [...]

December 10th, 2019|IVI News, Press|

IVI Showcases OSVP at HealthEconomics.com’s “Big Ideas Accelerating Change” Challenge

As one of the nine finalists in HealthEconomics.com's inaugural challenge competition to accelerate change in health economics and outcomes research, IVI's Mark Linthicum offered a compelling case for how IVI's Open-Source Value Platform (OSVP) is [...]

December 5th, 2019|IVI News|

IVI Submits Comments on ICER Draft Evidence Report on JAK Inhibitors for RA

IVI offered comments on ICER's recently released Draft Evidence Report examining the cost-effectiveness of Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis. In addition to commenting on the needs for transparency and the impacts of modeling [...]

November 13th, 2019|IVI News, Viewpoints|

Jennifer Bright Explains How IVI Economic Models Improve Process of Value Assessment

At the National Health Council's event, Back to School: Patient Community Training on Value Assessment, IVI executive director Jennifer Bright explains the non-profit organization's mission to make value assessment more relevant to real decision making, [...]

November 8th, 2019|Events, IVI News|

PRESS RELEASE: IVI Receives Eugene Washington PCORI Engagement Award

IVI has been selected by the Patient-Centered Outcomes Research Institute (PCORI) for a Eugene Washington PCORI Engagement Award. The $50,000 award will be used to convene a multi-stakeholder forum in February 2020 to review established [...]

October 8th, 2019|IVI News, Press|

IVI Comment Letter on ICER’s Proposed Methods for Curative Therapies

IVI submitted comments to ICER regarding proposed methodological changes for assessments of the value of single or short-term transformative (SST) therapies. IVI emphasized the need for ICER to address the potential use of its findings [...]

September 16th, 2019|IVI News|

PRESS RELEASE: How Structural Uncertainty Impacts Value Estimates

In a new Value Blueprints research brief, IVI explores the concept of “structural uncertainty,” an important source of uncertainty that is not generally measured or addressed in cost-effectiveness models. In this research brief, we use [...]

September 4th, 2019|IVI News, Press, Publications, Research|